AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (November 5, 2008). doi:10.1152/ajprenal.90487.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/1/F170    most recent
90487.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matavelli, L. C
Right arrow Articles by Majid, D. S.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matavelli, L. C
Right arrow Articles by Majid, D. S.A.
Submitted on August 13, 2008
Revised on October 23, 2008
Accepted on November 3, 2008

Renal hemodynamic and excretory responses to intra-arterial infusion of peroxynitrite in anesthetized rats

Luis C Matavelli1, Philip J Kadowitz2, L. Gabriel Navar3, and Dewan S.A. Majid3*

1 Tulane University Health Sciences Center
2 Tulane University, Health Sciences Center
3 Tulane University School of Medicine

* To whom correspondence should be addressed. E-mail: majid{at}tulane.edu.

Peroxynitrite (ONOO-) is formed endogenously by the reaction of nitric oxide (NO) and superoxide (O2-). To examine the hypothesis that OONO- cause renal vasodilation at low concentrations but cause vasoconstriction at higher concentrations, we examined renal responses to intra-arterial infusion of incremental doses of OONO- (10, 20, and 40 µg/kg/min; 45 min each) in anesthetized rats. Renal blood flow (RBF) and glomerular filtration rate (GFR) were determined by PAH and inulin clearance. In control rats (n = 6), low dose (10 µg/kg/min) of OONO- increased RBF by 10 ± 3% and GFR by 15 ± 5%. The higher doses (20 and 40 µg/kg/min) mostly reversed these responses which were -7 ± 4% and -27 ± 7% (P < 0.05) in RBF and -0.1 ± 4.8% and -14 ± 12% in GFR respectively. There were no appreciable changes in urine flow (V) and sodium excretion (UNaV) during OONO- infusion. However, in rats pre-treated with NO synthase (NOS) inhibitor, L-NAME (50 µg/kg/min; n = 5), these doses of ONOO- significantly reduced RBF (-26 ± 7, -27 ± 6% and -44 ± 3%) and GFR (-21 ± 6, -25 ± 8 and -32 ± 12%) with variable increases in V or UNaV. Long term infusion of OONO- (10 µg/kg/min for 75 min) in another set of control rats (n=5) also showed similar vasodilator and hyperfiltration responses. These data indicate that ONOO- acts as an oxidant at high concentration but provides reno-protective function at low concentration that depends on intact NOS activity.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.